4.8 Article

Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycan

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0906545106

关键词

dystroglycanopathy; glycosylation; integrin; membrane damage; muscular dystrophy

资金

  1. Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]
  2. Muscular Dystrophy Association [MDA3936]
  3. Muscular Dystrophy Association Development
  4. Welcome Trust [060549]
  5. U.S. Department of Defense [W81XWH-05-1-0079]

向作者/读者索取更多资源

Skeletal muscle basal lamina is linked to the sarcolemma through transmembrane receptors, including integrins and dystroglycan. The function of dystroglycan relies critically on posttranslational glycosylation, a common target shared by a genetically heterogeneous group of muscular dystrophies characterized by alpha-dystroglycan hypoglycosylation. Here we show that both dystroglycan and integrin alpha 7 contribute to force-production of muscles, but that only disruption of dystroglycan causes detachment of the basal lamina from the sarcolemma and renders muscle prone to contraction-induced injury. These phenotypes of dystroglycan-null muscles are recapitulated by Large(myd) muscles, which have an intact dystrophin-glycoprotein complex and lack only the laminin globular domain-binding motif on alpha-dystroglycan. Compromised sarcolemmal integrity is directly shown in Large(myd) muscles and similarly in normal muscles when arenaviruses compete with matrix proteins for binding alpha-dystroglycan. These data provide direct mechanistic insight into how the dystroglycan-linked basal lamina contributes to the maintenance of sarcolemmal integrity and protects muscles from damage.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Peripheral Vascular Disease

Angiotensin II and Amyloid-β Synergistically Induce Brain Vascular Smooth Muscle Cell Senescence

Hui-Yu Bai, Li-Juan Min, Bao-Shuai Shan, Jun Iwanami, Harumi Kan-no, Motoi Kanagawa, Masaki Mogi, Masatsugu Horiuchi

Summary: Ang II and A beta synergistically promote brain vascular smooth muscle cell senescence, possibly through enhancement of the p-ERK-p16-pRb signaling pathway, oxidative stress, and NF-kappa B/I kappa B activity.

AMERICAN JOURNAL OF HYPERTENSION (2021)

Article Biochemistry & Molecular Biology

Non-canonical autophagy functions of ATG16L1 in epithelial cells limit lethal infection by influenza A virus

Yingxue Wang, Parul Sharma, Matthew Jefferson, Weijiao Zhang, Ben Bone, Anja Kipar, David Bitto, Janine L. Coombes, Timothy Pearson, Angela Man, Alex Zhekova, Yongping Bao, Ralph A. Tripp, Simon R. Carding, Yohei Yamauchi, Ulrike Mayer, Penny P. Powell, James P. Stewart, Thomas Wileman

Summary: The study demonstrates that non-canonical autophagy in airway epithelial cells is a novel innate defense mechanism that restricts influenza virus infection and reduces lethal inflammation.

EMBO JOURNAL (2021)

Article Rheumatology

Involvement of Transient Receptor Potential Vanilloid Channel 2 in the Induction of Lubricin and Suppression of Ectopic Endochondral Ossification in Mouse Articular Cartilage

Hideki Nakamoto, Yuki Katanosaka, Ryota Chijimatsu, Daisuke Mori, Fengjun Xuan, Fumiko Yano, Yasunori Omata, Yuji Maenohara, Yasutaka Murahashi, Kohei Kawaguchi, Ryota Yamagami, Hiroshi Inui, Shuji Taketomi, Yuki Taniguchi, Motoi Kanagawa, Keiji Naruse, Sakae Tanaka, Taku Saito

Summary: This study reveals the regulation of articular cartilage by TRPV2 through Prg4 induction and suppression of ectopic ossification.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Clinical Neurology

Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis

Chiseko Ikenaga, Hidetoshi Date, Motoi Kanagawa, Jun Mitsui, Hiroyuki Ishiura, Jun Yoshimura, Iago Pinal-Fernandez, Andrew L. Mammen, Thomas E. Lloyd, Shoji Tsuji, Jun Shimizu, Tatsushi Toda, Jun Goto

Summary: This study explored the molecular features of inclusion body myositis (IBM) and found that the differentially expressed genes and pathways in IBM and polymyositis were mostly comparable. However, the pathways related to cell adhesion molecules were upregulated in IBM. The study also discovered the overexpression of the epidermal cell junction protein cadherin 1 in the muscles of IBM, which could provide valuable insights into the pathological mechanisms of IBM.

ANNALS OF NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy

Sarah J. Smith, Lacramioara Fabian, Adeel Sheikh, Ramil Noche, Xiucheng Cui, Steven A. Moore, James J. Dowling

Summary: Congenital muscular dystrophy type 1A (MDC1A) is a common genetic disorder caused by mutations in the LAMA2 gene. In this study, researchers used a zebrafish model to investigate the role of lysosome distribution in MDC1A. They found that abnormal lysosome distribution was associated with fiber detachment and could be improved by overexpression of a transcription factor called transcription factor EB. This suggests that targeting lysosome function may be a potential therapeutic strategy for treating MDC1A.

HUMAN MOLECULAR GENETICS (2022)

Article Genetics & Heredity

Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy

Megan A. Waldrop, Steven A. Moore, Katherine D. Mathews, Benjamin W. Darbro, Livja Medne, Richard Finkel, Anne M. Connolly, Thomas O. Crawford, Daniel Drachman, Nicolas Wein, Ali A. Habib, Monika A. Krzesniak-Swinarska, Craig M. Zaidman, James J. Collins, Manu Jokela, Bjarne Udd, John W. Day, Gloria Ortiz-Guerrero, Jeff Statland, Russell J. Butterfield, Diane M. Dunn, Robert B. Weiss, Kevin M. Flanigan

Summary: Deep intronic DMD mutations can be identified through muscle RNA analysis, which is an important diagnostic step for patients with abnormal dystrophin expression but negative genomic testing results. This study identified three types of pathogenic pseudoexon mutations and proposed potential treatment approaches based on the mutation type.

HUMAN MUTATION (2022)

Article Clinical Neurology

Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With SMCHD1 Variants

Payam Mohassel, Ning Chang, Kaoru Inoue, Angela Delaney, Ying Hu, Sandra Donkervoort, Dimah Saade, B. Jeanne Billioux, Brooke Meader, Rita Volochayev, Chamindra G. Konersman, Angela M. Kaindl, Chie-Hee Cho, Bianca Russell, Adrian Rodriguez, K. Wade Foster, A. Reghan Foley, Steven A. Moore, Peter L. Jones, Carsten G. Bonnemann, Takako Jones, Natalie D. Shaw

Summary: In this study, we identified individuals with arhinia who met the genetic and epigenetic criteria for FSHD2 and showed molecular hallmark of FSHD-DUX4 derepression and expression in vitro, but did not have the typical clinical phenotype of FSHD2. This suggests the presence of novel disease-modifying factors that operate as a switch between FSHD2 and arhinia phenotypes.

NEUROLOGY (2022)

Article Neurosciences

The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies

Nicole Becker, Steven A. Moore, Karra A. Jones

Summary: The inflammatory histopathology of dysferlinopathy is more similar to limb-girdle pattern muscular dystrophies than true inflammatory myopathies. Dysferlinopathy muscle biopsies have minimal inflammatory cell infiltrates, absent to focal MHC class I expression, and diffuse myofiber complement C5b-9 deposition.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model

Hideki Tokuoka, Rieko Imae, Hitomi Nakashima, Hiroshi Manya, Chiaki Masuda, Shunsuke Hoshino, Kazuhiro Kobayashi, Dirk J. Lefeber, Riki Matsumoto, Takashi Okada, Tamao Endo, Motoi Kanagawa, Tatsushi Toda

Summary: Ribitol-phosphate modifications are important for the maturation of alpha-dystroglycan, and defects in these modifications can lead to various diseases. This study demonstrates that prodrug treatments, specifically tetraacetylated CDP-ribitol, can ameliorate muscular dystrophy caused by defects in ISPD. These findings provide potential therapeutic options for muscular dystrophy and other glycosylation defects.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice

Anabel S. De La Garza-Rodea, Steven A. Moore, Jesus Zamora-Pineda, Eric P. Hoffman, Karishma Mistry, Ashok Kumar, Jonathan B. Strober, Piming Zhao, Jung H. Suh, Julie D. Saba

Summary: This study reveals that Duchenne muscular dystrophy (DMD) patients have increased expression of SPL and dysregulated S1P metabolism in skeletal muscles. Treatment with the SPL inhibitor LX2931 increases the number of muscle stem cells (SC), reduces leukocyte infiltration, and attenuates muscle inflammation and degeneration. The treatment also leads to changes in gene expression related to immune function, plasma membrane interactions, and axon guidance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Multidisciplinary Sciences

Control of infection by LC3-associated phagocytosis, CASM, and detection of raised vacuolar pH by the V-ATPase-ATG16L1 axis

Yingxue Wang, Maria Ramos, Matthew Jefferson, Weijiao Zhang, Naiara Beraza, Simon Carding, Penny P. Powell, James P. Stewart, Ulrike Mayer, Thomas Wileman

Summary: The delivery of pathogens to lysosomes for degradation is an important defense mechanism against infection. The activation of the V-ATPase-ATG16L1 axis and the stabilization of NADPH oxidase play crucial roles in facilitating the conjugation of LC3 to pathogens and promoting their degradation. However, many microbes have developed strategies to inhibit LC3 recruitment and avoid lysosomal degradation by blocking ROS production and the V-ATPase-ATG16L1 axis.

SCIENCE ADVANCES (2022)

Article Pharmacology & Pharmacy

Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies

Catherine I. Soderstrom, Jennifer Larsen, Carolina Owen, David Gifondorwa, David Beidler, Florence H. Yong, Patricia Conrad, Hendrik Neubert, Steven A. Moore, Mohamed Hassanein

Summary: Duchenne muscular dystrophy (DMD) is a degenerative muscular disease with no cure. New advances in gene therapy and understanding of the disease have opened up new treatment opportunities. This article describes a novel Western blot method for monitoring dystrophin expression and assessing treatment efficacy.

AAPS JOURNAL (2022)

Article Medicine, General & Internal

Ventriculus terminalis cyst in an infant: a case report

Arnold H. H. Menezes, Yutaka Sato, Brian J. J. Dlouhy, Karra A. A. Jones, Steven A. A. Moore

Summary: A Caucasian female neonate with ventriculus terminalis cyst, extra-axial conofilar cyst, and tethered lipomatous filum underwent surgical intervention due to progressive cyst enlargement. The cyst was excised and the lipomatous filum was sectioned during the surgery. The child had a good recovery without deficits at 4-year follow up.

JOURNAL OF MEDICAL CASE REPORTS (2023)

Article Multidisciplinary Sciences

DUX4 double whammy: The transcription factor that causes a rare muscular dystrophy also kills the precursors of the human nose

Kaoru Inoue, Hamed Bostan, MaKenna R. Browne, Owen F. Bevis, Carl D. Bortner, Steven A. Moore, Aaron A. Stence, Negin P. Martin, Shih-Heng Chen, Adam B. Burkholder, Jian-Liang Li, Natalie D. Shaw

Summary: SMCHD1 mutations cause congenital arhinia and FSHD2. Loss of SMCHD1 activity leads to DUX4 expression and cell death in placode cells derived from hESCs and iPSCs. Herpesvirus infection may amplify DUX4 expression in SMCHD1 KO cells, indicating an environmental disease modifier.

SCIENCE ADVANCES (2023)

Article Cell Biology

A De Novo Sequence Variant in Barrier-to-Autointegration Factor Is Associated with Dominant Motor Neuronopathy

Agathe Marcelot, Felipe Rodriguez-Tirado, Philippe Cuniasse, Mei-ling Joiner, Simona Miron, Alexey A. Soshnev, Mimi Fang, Miles A. Pufall, Katherine D. Mathews, Steven A. Moore, Sophie Zinn-Justin, Pamela K. Geyer

Summary: Barrier-to-autointegration factor (BAF) is an essential component of the nuclear lamina that regulates gene expression, cell cycle progression, and nuclear integrity. A dominant pathogenic BAF variant, Gly16Arg, has been identified in a patient with progressive neuromuscular weakness, causing changes in chromatin structure and nuclear functions. This study demonstrates how a missense mutation can alter protein conformation and lead to a dominant disease phenotype.
暂无数据